Pharmafile Logo
Pharmafocus logo
Advanced Search

brexit

Showing 15 posts of 137 posts found.

Sanofi may airlift flu vaccines into UK after Brexit

March 26, 2019
Manufacturing and Production EU, France, Sanofi, UK, brexit, channel tunnel, vaccines

French firm Sanofi would airlift flu vaccines into the UK in the case of a highly disruptive exit from the …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Acadia Pharmaceuticals, FDA, Sandoz, brexit, genomics, pharma, pharmacovigilance, top 10

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …

News
28246711066_52e38bc591_z

Healthcare industry could take up to five years to stabilise after no-deal Brexit

March 13, 2019
Manufacturing and Production, Medical Communications, Research and Development GlobalData, analysis, brexit, no-deal Brexit, surveys

The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …

News

More than 40% of GPs intend to quit within five years

February 28, 2019
Medical Communications GPs, NHS, NHS LOng term plan, UK, brexit, workforce

More than 40% of GPs intend to quit within five years according to researchers at the University of Warwick. The …

News
pharmafocus_march_2019_cover

Read the March 2019 issue of Pharmafocus online now!

February 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease

Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …

News
28246711066_52e38bc591_z

FMD would not apply in case of no-deal Brexit

February 8, 2019
Medical Communications EU, FMD, UK, brexit, falsified medicines

The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …

News
pharmafocus_janfeb_2019_cover

Read Pharmafocus January/February 2019 edition online now!

January 30, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines

We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …

News

Novartis warns of huge impact of no-deal Brexit

January 28, 2019
Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma

Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …

News

Government unveils £20bn plan to revitalise NHS in England

January 8, 2019
Manufacturing and Production NHS funding, NHS< funding, brexit, government, health, policy

Theresa May and the chief executive of NHS England, Simon Stevens, have announced a new ten year plan for the …

News
38707779504_4778627b30_z

Top Ten most popular articles on Pharmafile.com of 2018!

December 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10

Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10

Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …

News
4768764591_9e4f7f0eb8_z

No-deal Brexit stockpiling puts pressure on supply chain

December 17, 2018
Sales and Marketing brexit, no-deal, pharma, pricing, supply chain

The stockpiling of medicines in preparation for a no-deal Brexit is putting pressure on the supply chain and causing shortages …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit

Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …

News
28246711066_52e38bc591_z

Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit

December 7, 2018
Medical Communications Matt Hancock, NHS, UK, brexit, no-deal

British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …

News
brexit_flag

83% in healthcare say UK will not be attractive for R&D and manufacturing post-Brexit

November 30, 2018
Medical Communications, Research and Development R&D, UK, brexit, pharma

As the Brexit crisis continues to spiral, new findings from GlobalData reveal that 83% of healthcare professionals in the UK …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023